Department of Health Policy Archive — Page 14 of 15
-
May 1, 2014
Cutting-edge research to be showcased in May
-
April 24, 2014
Schaffner honored by pharmacy association
William Schaffner, M.D., professor of Preventive Medicine at Vanderbilt University Medical Center, received the Immunization Champion Award — Friend of Pharmacy from the American Pharmacists Association (APA) at the group’s annual meeting recently in Orlando, Fla. -
March 27, 2014
Flu boosts pneumococcal colonization
Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia. -
February 20, 2014
Aliyu to receive preventive medicine ‘Rising Star’ award
Muktar Aliyu, M.D., associate professor of Health Policy and Medicine, is receiving the William Kane Rising Star Award from the American College of Preventive Medicine (ACPM) at its annual banquet on Saturday in New Orleans. -
December 9, 2013
Penicillin equally effective as ‘big gun’ antibiotics for treating less severe childhood pneumonia, Vanderbilt study shows
Children hospitalized for pneumonia have similar outcomes, including length of stay and costs, regardless of whether they are treated with “big gun” antibiotics such as ceftriaxone or cefotaxime or more narrowly focused antibiotics such as ampicillin or penicillin. -
October 17, 2013
Pharmacogenomic testing costs studied
A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions. -
August 22, 2013
Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk
Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.